Quest Diagnostics Inc Other Restructuring Costs
Quest Diagnostics Inc (DGX) reported Other Restructuring Costs of $0 for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-10-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherRestructuringCosts · last filed 2019-10-23
- Quest Diagnostics Inc other restructuring costs for the quarter ending 2019-09-30 was $0.00.
- Quest Diagnostics Inc other restructuring costs for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- Quest Diagnostics Inc other restructuring costs for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- Quest Diagnostics Inc other restructuring costs for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
| Period end | Other Restructuring Costs 3 month | Other Restructuring Costs 6 month | Other Restructuring Costs 9 month |
|---|---|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-10-23 | $0.00 derived: sum of 2 quarters · filed 2019-10-23 | $0.00 10-Q · filed 2019-10-23 |
| 2019-06-30 | $0.00 10-Q · filed 2019-07-24 | $0.00 10-Q · filed 2019-07-24 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-04-24 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-10-23 | $3.00M derived: sum of 2 quarters · filed 2019-10-23 | $4.00M 10-Q · filed 2019-10-23 |
| 2018-06-30 | $3.00M 10-Q · filed 2019-07-24 | $4.00M 10-Q · filed 2019-07-24 | |
| 2018-03-31 | $1.00M 10-Q · filed 2019-04-24 | ||
| 2017-09-30 | $1.00M 10-Q · filed 2018-10-24 | $2.00M derived: sum of 2 quarters · filed 2018-10-24 | $2.00M 10-Q · filed 2018-10-24 |
| 2017-06-30 | $1.00M 10-Q · filed 2018-07-25 | $1.00M 10-Q · filed 2018-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |